Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F22%3A00555407" target="_blank" >RIV/68081707:_____/22:00555407 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/22:00075993 RIV/00209805:_____/22:00078890 RIV/00179906:_____/22:10449864 RIV/00216224:14310/22:00125067
Result on the web
<a href="https://link.springer.com/article/10.1007/s43440-021-00338-9" target="_blank" >https://link.springer.com/article/10.1007/s43440-021-00338-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s43440-021-00338-9" target="_blank" >10.1007/s43440-021-00338-9</a>

Result language
angličtina
Original language name
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma
Original language description
Background Hepatocellular carcinoma (HCC) is a major contributor to the worldwide cancer burden. Recent studies on HCC have demonstrated dramatic alterations in expression of several cytochrome P450 (CYP) family members that play a crucial role in biotransformation of many drugs and other xenobiotics, however, the mechanisms responsible for their deregulation remain unclear.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy

Project
<a href="/en/project/NV17-28231A" target="_blank" >NV17-28231A: Expression of biotransformation enzymes in primary liver cancers</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)